What is a characteristic of epidemic meningitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Epidemic meningitis is typically seasonal, occurring during the dry season in certain regions, such as the "meningitis belt" in sub-Saharan Africa, which spans from Senegal to Ethiopia 1.

Characteristics of Epidemic Meningitis

  • Geographic distribution: Epidemics of meningococcal disease are recurrent in the "meningitis belt" of sub-Saharan Africa, which extends from Senegal in the West to Ethiopia in the East 1
  • Seasonality: Epidemics in the meningitis belt usually occur during the dry season, from December to June 1
  • Incidence rate: An average incidence rate of disease that exceeded 15 cases/100,000/week for a period of 2 consecutive weeks was predictive of an epidemic 1

Identification and Control

  • Outbreak identification: Early priority should be given to the determination of etiology and serogroup, which may be accomplished through the use of latex agglutination tests 1
  • Antibiotic resistance patterns: It is also important to determine antibiotic resistance patterns to guide treatment and control efforts 1

From the Research

Characteristics of Epidemic Meningitis

  • Epidemic meningococcal meningitis is a major health problem in sub-Saharan Africa, accounting for thousands of deaths and causing morbidity in hundreds of thousands of people 2
  • The disease is caused by Neisseria meningitidis, with serogroup A being responsible for the largest and most recent epidemics in Africa 2
  • The age group at highest risk of disease is typically 6 months-30 years old, although recent epidemics have seen high age-specific attack rates in those aged 30 years and over 2
  • Epidemic meningitis is characterized by a high incidence rate, with the WHO proposing a cutoff of 15 cases/100,000/week averaged over two weeks for early detection of an emerging epidemic 2
  • The disease can spread quickly, with person-to-person transmission occurring through inhalation of droplets of infected nasopharyngeal secretions by direct or indirect oral contact 3
  • Epidemic meningitis can have a high mortality rate, with overall mortality due to meningitis usually around 10 per cent, and case fatality rates exceeding 50 per cent in cases of meningococcal septicemia 3

Geographic Distribution

  • Epidemic meningococcal meningitis is primarily found in the "meningitis belt" of sub-Saharan Africa, which includes countries such as Guinea-Bissau, Guinea, Côte d'Ivoire, Togo, and others 2, 4
  • The disease can also occur in other parts of Africa, as well as in other regions of the world, including Asia and the Americas 4, 5

Prevention and Control

  • Prevention and control strategies for epidemic meningitis include vaccination, chemoprophylaxis, and early detection and treatment 5, 3
  • Mass vaccination campaigns can be effective in halting an epidemic of meningococcal disease due to serogroup A or C 3
  • Public health approaches to outbreaks of meningococcal meningitis include early detection, confirmation of the epidemic, and implementation of control measures such as vaccination and chemoprophylaxis 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Meningococcal meningitis outbreak control strategies.

The Journal of communicable diseases, 2000

Research

Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.